SRC and breast cancer: Downregulation of the cytoskeleton genes, connexin 43, induces tamoxifen-resistance in breast cancer [35] cells via activation of c-Src/PI3K/Akt signaling and Epithelial to mesenchymal transition (EMT) of cells.